Deuteration as a General Strategy to Enhance Small Molecule-Based Photodynamic Therapy
Utilizing isotope effects has a long history in organic chemistry, and has recently been shown to improve fluorophore photophysics and azobenzene-based photoswitch kinetics. Herein, we report the deuteration of methylene blue (MB) and sulfonated tetraphenyl porphyrin (TPPS), both far-red singlet oxygen sensitizers (SOSs), which boosts the efficiency of reactive oxygen species (ROS) generation by >55%. We applied this knowledge to photodynamic therapeutic (PDT) settings by derivatizing deuterated methylene blue as 1) a ligand for the HaloTag protein (HTP) that leads to faster activation kinetics of the ROS-sensitive TRAAK channel, 2) as a fusion to a peptidic agonist of the glucagon-like peptide 1 receptor (GLP1R) to optically induce ablation of GLP1R-expressing cells, and 3) as a lysosome targeting sensitizer to induce spatiotemporally controlled lysosomal damage through lipid oxidation. Taken together, our strategy provides a simple way to improve well-studied singlet oxygen sensitizers through deuteration and leverages the best performing sensitizer across a set of different biological methodologies to study ion channel gating, as well as organelle and cell ablation.
Authors
- Marion Bied (ORCID: https://orcid.org/0000-0002-6467-4552)
- Volker Haucke (ORCID: https://orcid.org/0000-0003-3119-6993)
- Johannes Broichhagen (ORCID: https://orcid.org/0000-0003-3084-6595)
- Arnaud Landra-Willm
- David J. Hodson (ORCID: https://orcid.org/0000-0002-8641-8568)
- Guillaume Sandoz (ORCID: https://orcid.org/0000-0003-1251-0852)
- Kilian Roßmann (ORCID: https://orcid.org/0000-0003-4965-9669)
- Chen Song (ORCID: https://orcid.org/0000-0002-0560-4386)
- Michael Ebner (ORCID: https://orcid.org/0000-0003-4234-7187)
- Ramona Birke (ORCID: https://orcid.org/0009-0003-9899-2502)
- Yanwei Su
Institutions
- Centre National de la Recherche Scientifique (FR)
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- Berlin School of Economics and Law (DE)
- Centre Hospitalier Universitaire de Nice (FR)
- University of Oxford (GB)
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (DE)
- NeuroCure Cluster of Excellence (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- ChemRxiv
- Published
- 2026-11-17
- DOI
- https://doi.org/10.26434/chemrxiv.15012344/v1
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- preprint
Funders
- UK Research and Innovation
- National Institute for Health and Care Research
- Diabetes UK
- European Commission
- Deutsche Forschungsgemeinschaft
- HORIZON EUROPE Framework Programme